Clark+Elbing
Emily Legan, PhD, is a Technology Specialist at Clark+Elbing LLP since April 2023, following extensive research experience in biochemistry and cell biology. At Emory University Department of Pediatrics from May 2018 to November 2022, Emily conducted dissertation research in the Renhao Li Lab, focusing on the regulation and activation mechanisms of von Willebrand factor. Prior to this, Emily interned at the BloodCenter of Wisconsin, studying clathrin-mediated endocytosis in platelets, and served as a writing tutor at the Norman H. Ott Memorial Writing Center. Emily's academic journey began with an undergraduate research assistant role under Dr. Anita Manogaran at Marquette University, investigating prion formation. Emily holds a PhD in Biochemistry, Cell, and Developmental Biology from Emory University and a BS in Biochemistry and Molecular Biology, graduating magna cum laude from Marquette University.
Clark+Elbing
Clark+Elbing is a top-tier intellectual property (IP) law firm focused on protecting and promoting innovations in life science, chemistry, devices, and diagnostics. Founded in 1996 by a group with a shared passion for science, our firm has a long-held reputation as a premier law firm for patents. We are proud to offer a robust team of IP attorneys with advanced degrees in science who are supported by a group of Ph.D.s who are at the forefront of scientific innovation. We are as curious, collaborative, precise, and creative as you are. We are unapologetic science enthusiasts with a deep appreciation for technology. We understand what it is, how it works, why it matters – and what it is worth. That’s why clients like you prefer to work with us. We get it, and we get you. Our clients span the business spectrum and the globe. We represent clients from start-ups to multinational corporations and the investors that fund them, as well as world-class universities and medical centers.